Renal stone analysis is performed by the majority of chemical pathology laboratories. There is currently growing concern that the analytical process is poorly controlled and evidence is accumulating that both quantitative and qualitative analyses are frequently unreliable.' Whilst it is clearly important that we improve the standards of our analytical techniques, I think we must also stand back and re-evaluate the clinical value of these analyses. It might seem logical that knowledge of stone composition would reveal the nature of any underlying metabolic disturbance, but this is not necessarily the case even if we set aside any considerations of analytical accuracy. To appreciate the inadequacies of stone analysis in this respect it is necessary to consider the causes of stone formation.
RENAL STONE FORMATION
Various factors are important contributors to the precipitation and growth of crystals within the urinary tract.? the most obvious being an increase in the concentration of a urinary constituent above its natural solubility. This may be the result of an inborn error of metabolism where there is an elevated excretion of unusual metabolites, the most common being cystine. It may also arise as a result of an acquired metabolic disturbance with an increased excretion of a normal urinary constituent, usually calcium or oxalate. These stones are generally referred to as 'metabolic stones'. 3 Precipitation may be enhanced by a deficiency of the physiological inhibitors of stone growth, principally mucopolysaccharides, citrate and pyrophosphate." Changes in pH also affect the solubility of many metabolites.' The normal diurnal variability of urinary pH, with an alkaline tide following meals, can affect the nature of material that precipitates.P It is more difficult for crystals to form spontaneously than for material to precipitate on to a pre-existing nidus. This gives rise to the phenomenon known as epitaxy whereby stone growth is often heterogeneous.s-' the bulk of a stone being quite different in composition from its nucleus. As many as 10070 of stones formed by patients with cystinuria contain no detectable cystine," although it is likely that cystine crystallization is important in the aetiology of these stones.
Another confounding factor is that stone growth is frequently asymmetrical. Thus a section through a stone will not necessarily reveal the original nidus and even sophisticated analyses of each stone layer may well fail to identify the originating material.
URINARY TRACT INFECTION
There is a strong association between urolithiasis and urinary tract infections.! and it is usually impossible to determine which was the primary event. Urinary tract infections predispose to the growth of stones, especially where the infecting organisms produce urease. 9 The release of ammonia from urea increases urinary pH and the concentration of the ammonium ion. This increases the likelihood of the precipitation of calcium phosphate and magnesium ammonium phosphate. The latter is commonly referred to as struvite and is recognized as being infection-related material. Conversely, the presence of a stone in the urinary tract predisposes to infection, the stone being a relatively secure environment in which bacteria can survive. Electron microscopic studies provide evidence of the colonization of stone surfaces by bacteria. 10 Thus, infection-related material will often deposit on to a pre-existing stone and may eventually form the bulk of the stone. The presence of calculi in the urinary tract may also lead to stasis, which in turn increases the risk of infection. Urinary tract infections are a common complication of metabolic disorders that predispose to urolithiasis." Thirty per cent of cystinuric patients in one study were shown to suffer from repeated urinary tract infections.'?
Quantitative information about the composition of a stone is, therefore, of little value for the investigation of the cause of urolithiasis, particularly in respect of the 'infection-related material' whose presence may be primary or secondary to the existence of the stone.
HOW SHOULD WE INVESTIGATE RENAL STONE DISEASE?
The emphasis must be on the examination of the composition of urine and plasma.'! In the first instance it is essential that the clinical history be examined for evidence of recognizable risk factors. These include immobilization, persistently low urine volume;" excessive animal protein, salt or vitamin D in the diet;" clinical disorders associated with renal tubular acidosis and chemotherapy. Metabolic investigations should then be undertaken with the patient maintaining his or her usual diet. Patients who are recurrent stone formers will obviously merit a more thorough metabolic investigation than those who form only one stone." However, any of these investigations should be delayed if there is evidence of an active urinary tract infection because some compounds, notably cystine, can be metabolized by infecting organisms.
Analyses on urine must include early morning pH and calcium, urate, phosphate, oxalate and cystine concentrations. In my experience the cyanide/nitroprusside spot test is not reliable enough to exclude cystinuria and simple chromatography, for example thin layer, is recommended. Inborn errors of metabolism associated with urolithiasis are characterized by a consistent elevation in the urinary concentration of the abnormal metabolite, and therefore these diagnoses should not be missed by analysing urine. Analyses on plasma must include calcium, albumin, urate, phosphate and creatinine concentrations. I? Where a disorder of purine metabolism is suspected from either high or low plasma urate concentrations, samples should be Ann Clin Biochem 1995: 32 referred to a specialist laboratory (for example the Purine Research Laboratory, Guy's Hospital, London, UK). This is necessary because there is growing recognition that dihydroxyadenine urolithiasis is an under-diagnosed condition.":" I do not believe that we can abandon routine stone analysis altogether, because we can never be sure that every patient who presents with urolithiasis is investigated thoroughly. The calculus may be the only sample sent to the laboratory. However, in my view simple qualitative tests 20 are sufficient to identify rare metabolic or factitious" stones and indicate the presence of infection-related material.
